Pediatric Perfusion: Critical Driver Shaping the Pediatric Perfusion Market Surges Amidst Rising Prevalence Of Cardiac Congenital Disorders Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pediatric Perfusion Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pediatric perfusion has experienced robust expansion in the previous years. An increase from $2.66 billion in 2024 to $2.83 billion in 2025 is projected, implying a compound annual growth rate (CAGR) of 6.5%. Factors contributing to the growth during the historic period include significant advancements in pediatric cardiac surgery, the development of innovative perfusion methods, the evolution of pediatric perfusion equipment, foundational research in the field of pediatric cardiology, and the establishment of specialized pediatric heart centers.

Pediatric Perfusion Market Size Forecast: What's the Projected Valuation by 2029?
The market size for pediatric perfusion is projected to witness considerable growth in the foroming years. By 2029, it's expected to reach a value of $4.01 billion, growing at a compound annual growth rate (CAGR) of 9.1%. The expansion of pediatric cardiac services globally, advancements in neuroprotection, and increased investment in pediatric cardiac care, combined with the tailoring of perfusion solutions and an increase in the use of hybrid operating rooms are factors contributing to this growth. Key trends during this period are anticipated to include research in pediatric cardiac care, ongoing education and training, a heightened focus on neuroprotection, the development of pediatric-specific equipment, and the advancement of cannulation techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pediatric-perfusion-global-market-report

What Are the Drivers Transforming the Pediatric Perfusion Market?
The increasing occurrence of heart-related birth defects is anticipated to boost the pediatric perfusion market's expansion in the future. These defects present at birth can affect a baby's heart's growth and functionality, altering how blood circulates from the heart to the rest of the body's organs. Pediatric perfusion is widely employed in cardiac surgeries to mend or rectify these heart structure abnormalities. Operations may include procedures such as ventricular septal defect (VSD) repair, atrial septal defect (ASD) repair, tetralogy of Fallot (TOF) repair, coarctation of the aorta repair, and many others. For instance, The World Health Organization stated in February 2023 that congenital diseases are estimated to cause 240,000 worldwide newborn deaths within 28 days of birth each year. Moreover, a report issued by the Centers for Disease Control (CDC) in January 2022 disclosed that congenital cardiac irregularity affects around 40,000 births annually in the United States, accounting for around 1% of the worldwide population. Consequently, the increasing incidence of heart-related birth defects is spurring the growth of the pediatric perfusion market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10717&type=smp

What Are the Key Trends Driving Pediatric Perfusion Market Growth?
Product enhancements are increasingly trending in the pediatric perfusion market, with leading market participants focusing on developing novel technologies like cardiopulmonary bypass (CPB), cardiovascular perfusion, and advanced extracorporeal technologies such as miniaturized extracorporeal circulation (MECC) systems, pediatric cardiac surgery mechanisms, sophisticated oxygenators, and secure-loop perfusion systems. For instance, in March 2023, LivaNova, a medical device producer based in the UK, unveiled the Essenz Heart-Lung Machine in the US, receiving a 510(k) clearance from the US Food and Drug Administration. The patient monitor from LivaNova and the Essenz Heart-Lung Machine together constitute a perfusion system used during cardiopulmonary bypass operations. This perfusion system plays the role of the patient's heart and lungs during open-heart surgery. The machine is versatile and can be used for both adults and children and is mast-mounted for minimal distraction and cleanliness. The cockpit provides a centralized control point for the machine, enabling monitoring of all perfusion data and patient info and connecting with external operating room tools and hospital data systems.

Which Segments in the Pediatric Perfusion Market Offer the Most Profit Potential?
The pediatric perfusion market covered in this report is segmented -

1) By Product: Pediatric Cannulae, Pediatric Centrifugal Blood Pumps, Pediatric Arterial Filters, Hem concentrators, HMS Plus Hemostasis Management System, Pediatric Oxygenators
2) By Procedure Type: Pediatric Cardiac Surgeries, Pediatric Organ Transplantation, Pediatric Extracorporeal Life Support (ECLS)
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:
1) By Pediatric Cannulae: Venous Cannulae, Arterial Cannulae, Dual-Lumen Cannulae
2) By Pediatric Centrifugal Blood Pumps: Continuous Flow Pumps, Pulsatile Pumps, Disposable Blood Pumps
3) By Pediatric Arterial Filters: Inline Arterial Filters, Bubble Traps, Microaggregate Filters
4) By Hemoconcentrators: Ultra-Filtration Hemoconcentrators, Continuous Renal Replacement Therapy (CRRT) Devices, Dialysis Hemoconcentrators
5) By HMS Plus Hemostasis Management System: Blood Coagulation Monitoring Devices, Platelet Function Test Systems, Point-Of-Care Testing Devices
6) By Pediatric Oxygenators: Membrane Oxygenators, Bubble Oxygenators, Extracorporeal Membrane Oxygenation (ECMO) Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10717&type=smp

Which Firms Dominate the Pediatric Perfusion Market by Market Share and Revenue in 2025?
Major companies operating in the pediatric perfusion market include Medtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, B. L. Lifesciences Pvt. Ltd., Eurosets, GE Healare Technologies Inc., Nonin Medical Inc., Koninklijke Philips N.V., Sorin Group, Cardinal Health Inc, Fluigent, Getinge AB, Xvivo Perfusion AB, Masimo Corporation, Philips Healare, Edwards Lifesciences Corporation, Maquet Holding B.V. & Co. KG, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomédica, Leviticus Cardio Ltd., Medos Medizintechnik AG, Beijing Medos Electronic Medical Equipment Co. Ltd., Medline Industries Inc., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, SynCardia Systems LLC, Xenios AG

Which Regions Offer the Highest Growth Potential in the Pediatric Perfusion Market?
North America was the largest region in the pediatric perfusion market in 2024. The regions covered in the pediatric perfusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10717

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.